Genetic heterogeneity of the immunogenic viral capsid protein region of human parvovirus B19 isolates obtained from an outbreak in a pediatric ward.
Whereas human parvovirus B19 commonly infects children and causes erythema infectiosum, it causes more severe diseases when it infects adults. In order to examine whether different clinical outcomes of B19 infection can be ascribed to the viral genetic heterogeneity, we have determined the nucleotide sequence of highly immunogenic portions of the B19 genome obtained from six patients with various clinical manifestations in a single outbreak. Our observations demonstrated that although the B19 sequences showed a significant heterogeneity, it was not correlated with the clinical manifestation. It was thus suggested that the host immune response to B19 infection may be a major determinant of clinical presentations associated with acute B19 infection.
Takahashi
N
N
Department of Molecular Genetics, Nagoya City University Medical School, Nagoya, Japan.
Takada
N
N
Hashimoto
T
T
Okamoto
T
T
D000328:Adult; D001483:Base Sequence; D002213:Capsid / Q000235:genetics*; D036022:Capsid Proteins; D002648:Child; D004279:DNA, Viral; D004196:Disease Outbreaks; D016731:Erythema Infectiosum / Q000453:epidemiology / Q000821:virology; D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D008969:Molecular Sequence Data; D010322:Parvoviridae Infections / Q000453:epidemiology / Q000821:virology*; D016732:Parvovirus B19, Human / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification; D010802:Phylogeny
D036022:Capsid Proteins; D004279:DNA, Viral; C095547:capsid protein VP1, parvovirus B19; C095548:capsid protein VP2, parvovirus B19